Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

High Sensitivity Immunoassays for C-Reactive Protein: Promises and Pitfalls

Thomas B. Ledue / Nader Rifai

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 39, Issue 11, Pages 1171–1176, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2001.185, June 2005

Publication History

Published Online:
2005-06-01

Abstract

C-reactive protein (CRP) has historically been measured in the clinical laboratory for the detection and monitoring of occult infection and inflammation, using immunoturbidimetric or immunonephelometric techniques. The recent commercial availability of automated high-sensitivity assays has enabled investigators to measure CRP at levels previously unattainable on a routine basis and to explore its clinical utility in apparently healthy individuals. CRP concentrations increased above the individuals' baselines but still within the normal reference intervals have been observed in association with increasing age, obesity, and smoking and in individuals with chronic infections such as Chlamydia pneumoniae and Helicobacter pylori. More importantly, however, data from prospective studies have shown CRP to be a strong and independent predictor of future coronary events in subjects with and without coronary heart disease. An algorithm for risk assessment of coronary risk employing both CRP and lipid concentrations has recently been proposed. However, in order for this approach to be incorporated into clinical practice, agreement among the various CRP methods must be achieved. Of critical importance to this process is a basic understanding of issues affecting assay performance. Factors such as assay precision, sensitivity, matrix effects, calibration, and standardization need to be addressed adequately by the in vitro diagnostic industry and the clinical laboratory.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Louisa M. Holmes and Enrico A. Marcelli
Health & Place, 2012, Volume 18, Number 3, Page 683
[2]
Sreenivasa Saravan Kallempudi and Yasar Gurbuz
Sensors and Actuators B: Chemical, 2011, Volume 160, Number 1, Page 891
[3]
Amélie Cartier, Mélanie Côté, Isabelle Lemieux, Louis Pérusse, Angelo Tremblay, Claude Bouchard, and Jean-Pierre Després
Metabolism, 2009, Volume 58, Number 10, Page 1452
[5]
Alexandra Vodolazkaia, Xavier Bossuyt, Amelie Fassbender, Cleophas M Kyama, Christel Meuleman, Karen Peeraer, Carla Tomassetti, and Thomas M D'Hooghe
Reproductive Biology and Endocrinology, 2011, Volume 9, Number 1, Page 113
[6]
Wen-Bin Lee, Yin-He Chen, Hsin-I Lin, Shu-Chu Shiesh, and Gwo-Bin Lee
Sensors and Actuators B: Chemical, 2011, Volume 157, Number 2, Page 710
[7]
Michael H. Davidson, Kevin C. Maki, Mary R. Dicklin, Steven B. Feinstein, MarySue Witchger, Marjorie Bell, Darren K. McGuire, Jean-Claude Provost, Harley Liker, and Michael Aviram
The American Journal of Cardiology, 2009, Volume 104, Number 7, Page 936
[8]
Anjum Quershi, Yasar Gurbuz, Weng P. Kang, and Jimmy L. Davidson
Biosensors and Bioelectronics, 2009, Volume 25, Number 4, Page 877
[9]
Nader Rifai and Paul M Ridker
Current Opinion in Lipidology, 2002, Volume 13, Number 4, Page 383
[10]
Mary M. Kimberly, Gerald R. Cooper, and Gary L. Myers
Diabetes Technology & Therapeutics, 2006, Volume 8, Number 1, Page 37
[11]
Mika Skeppholm, N. Håkan Wallén, Margareta Blombäck, and Anders Kallner
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 8
[12]
Parag H. Joshi and Terry A. Jacobson
Current Atherosclerosis Reports, 2010, Volume 12, Number 1, Page 34
[13]
Serap Semiz, Simin Rota, Özmert Özdemir, Ayşegül Özdemir, and Bünyamin Kaptanoğlu
Pediatrics International, 2008, Volume 50, Number 4, Page 419
[14]
A. Bini, S. Centi, S. Tombelli, M. Minunni, and M. Mascini
Analytical and Bioanalytical Chemistry, 2008, Volume 390, Number 4, Page 1077
[15]
Caroline E. Stigant, Ognjenka Djurdjev, and Adeera Levin
International Urology and Nephrology, 2005, Volume 37, Number 1, Page 133
[16]
Makoto HIURA, Toru KIKUCHI, Keisuke NAGASAKI, and Makoto UCHIYAMA
Hypertension Research, 2003, Volume 26, Number 7, Page 541
[17]
Nathalie Terrier, Lynne Senecal, Anne-Marie Dupuy, Isabelle Jaussent, Cecile Delcourt, Helene Leray, Silje Rafaelsen, Jean-Yves Bosc, Francois Maurice, Bernard Canaud, and Jean-Paul Cristol
Hemodialysis International, 2005, Volume 9, Number 2, Page 159

Comments (0)

Please log in or register to comment.